| Literature DB >> 33184335 |
Maria Arroyas1,2, Cristina Calvo3,4,5,6, Santiago Rueda7, Maria Esquivias7, Cristina Gonzalez-Menchen7, Ersilia Gonzalez-Carrasco8,3, Maria Luz Garcia-Garcia9,10,11.
Abstract
Our main objective was to study respiratory evolution and pulmonary and cardiac function in adolescents born preterm in the post-surfactant era. Observational cross-sectional study, comparing very preterm (< 32 weeks) and moderately-late preterm adolescents (≥ 32 weeks) (74 each group). We recorded respiratory symptoms, spirometry and functional echocardiogram. Very preterm adolescents required more respiratory admissions (45.9% vs. 28.4%) (p = 0.03, OR 2.1, CI95% 1.1-4.2) and had more current asthma (21.6% vs. 9.5%, p = 0.04, OR 2.3, CI95% 1.1-5.2). Preterm subjects with intrauterine growth restriction (IUGR) presented lower FEV1 (88.7 ± 13.9 vs. 95.9 ± 13.3, p = 0.027) and lower FVC (88.2 ± 13.6 vs. 95.5 ± 13.3, p = 0.025). When assessing right ventricle, very preterm showed a greater E/E' ratio (p = 0.02) and longer myocardial performance index (MPI) (p = 0.001). Adolescents with IUGR showed less shortening fraction (p = 0.016), worse E/E' ratio (p = 0.029) and longer MPI (p = 0.06). Regarding left ventricle, very preterm showed less E' wave velocity (p = 0.03), greater E/E' ratio (p = 0.005) and longer MPI (p < 0.001). Gestational age < 32 weeks is independently associated with current asthma in adolescence. Children 13-14 years old born very preterm required more respiratory admissions and had poorer diastolic and global function of both ventricles. IUGR is a risk factor for poorer lung function in preterm adolescents, regardless gestational age.Entities:
Year: 2020 PMID: 33184335 PMCID: PMC7661536 DOI: 10.1038/s41598-020-76614-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Perinatal characteristics of very preterm and moderately-late preterm.
| < 32 weeks N = 74 | ≥ 32 weeks N = 74 | Odds Ratio (CI 95%) | ||
|---|---|---|---|---|
| Male gender | 36 (48.6%) | 38 (51.4%) | 0.9 (0.7–1.3) | 0.869 |
| Multiple pregnancy | 22 (29.7%) | 22 (29.7%) | 1 (0.6–1.6) | 1 |
| Intrauterine growth restriction | 6 (8.1%) | 14 (18.7%) | 0.43 (0.17–1) | 0.050 |
| Preeclampsia | 16 (14.9%) | 13 (17.6%) | 0.8 (0.42–1.6 | 0.500 |
| Maternal smoking in pregnancy | 11 (14.9%) | 17 (23%) | 0.6 (0.3–1.2) | 0.200 |
| Maternal age > 35 years | 24 (32.4%) | 16 (21.6%) | 1.5 (0.8–2.6) | 0.140 |
| Gestational age (weeks)* | 28.0 ± 1.9 | 34.2 ± 1.2 | < 0.001 | |
| Newborn weight (g) | 1096 ± 363 | 2041 ± 526 | < 0.001 | |
| z-score** | − 0.11 ± 1.25 | − 0.66 ± 1.21 | 0.006 | |
| BPD | 21 | 0 | < 0.001 | |
| Surfactant therapy | 41 (55.4%) | 2 (2.7%) | 0.05 (0.01–0.19) | < 0.001 |
| Patent ductus arteriosus | 19 (25.7%) | 0 | 1.35 (1.2–1.5) | < 0.001 |
| Noninvasive mechanical ventilation (NIMV) | 57 (77%) | 5 (6.8%) | 11.4 (4.8–20.2) | < 0.001 |
| Duration NIMV | 6.8 ± 9.7 | 1.2 ± 0.7 | 0.070 | |
| Invasive mechanical ventilation | 48 (68.9%) | 3 (4.1%) | < 0.001 |
*Mean ± standard deviation.
**Z-score Fenton 2013.
Respiratory evolution of the Study Groups at Follow-Up according to gestational age.
| < 32 weeks N = 74 | ≥ 32 weeks N = 74 | Odds ratio Confidence Interval 95% | ||
|---|---|---|---|---|
| Respiratory admissions | 34 (46%) | 21 (28%) | 2.1 (1.1–4.2) | 0.030 |
| Respiratory ICU admissions | 9 (12%) | 2 (2.7%) | 4.5 (1.1–20.1) | 0.030 |
| Montelukast | 58 (78%) | 57 (77%) | 1.1 (0.5–2.3) | 0.843 |
| Inhaled corticosteroids | 35 (47%) | 16 (22%) | 3.3 (1.6–6.7) | 0.001 |
| Allergic sensitization | 21 (54%) | 27 (40%) | 1.7 (0.8–2.3) | 0.177 |
| Parental asthma | 16(12%) | 16 (12%) | 1.0 (0.4–2.4) | 1 |
| Parental atopy | 30 (40.5%) | 23 (31%) | 1.5 (0.8–2.9) | 0.230 |
Predicted influence of gender, IUGR and gestational age < 32 weeks on lung function at adolescence among all participating children.
| Regression coefficient | 95% CI of regression coefficient | P value | R2 | Adjusted R2 | ||
|---|---|---|---|---|---|---|
| FEV-1 | GA < 32 weeks | 0.02 | − 3.5 to 4.9 | 0.757 | 0.130 | 0.112 |
| IUGR | 0.14 | − 0.9 to 11.6 | 0.070 | |||
| Female | − 0.34 | − 12.7 to − 4.3 | < 0.001 | |||
| FVC | GA < 32 weeks | 0.03 | − 3.5 to 4.9 | 0.736 | 0.110 | 0.092 |
| IUGR | 0.1 | − 5.9 to 12.0 | 0.080 | |||
| Female | − 0.3 | − 11.7 to − 3.2 | 0.001 | |||
| FEF 25–75 | GA < 32 weeks | 0.2 | − 0.1 to 14.7 | 0.050 | 0.085 | 0.066 |
| IUGR | 0.1 | − 4.9 to 17.1 | 0.278 | |||
| Female | − 0.2 | − 17.7 to − 2.9 | 0.007 | |||
Blood pressure at adolescence according gestational age and the occurrence of intrauterine growth restriction (IUGR).
| < 32 weeks N = 74 | ≥ 32 weeksN = 74 | ||
|---|---|---|---|
| Systolic blood pressure* | 110 (19.8) | 110 (20) | 0.510 |
| Systolic blood pressure z-score* | 0.34 (1.3) | 0.34 (1.3) | 0.178 |
| Diastolic blood pressure* | 62 (10) | 60 (8.8) | 0.040 |
| Diastolic blood pressure z-score* | 0.08 (1) | − 0.36 (0.73) | 0.003 |
*Median (Interquartile range).
Values of right ventricle’s function obtained by echocardiography at adolescence according gestational age and the occurrence of intrauterine growth restriction (IUGR).
| < 32 weeks N = 74 | ≥ 32 weeks N = 74 | IUGR N = 20 | Non-IUGR N = 128 | |||
|---|---|---|---|---|---|---|
| Length (mm)* | 72.2 ± 2 | 65.9 ± 11 | 0.17 | 64 ± 8.5 | 65 ± 9.0 | 0.600 |
| Basal diameter (mm)* | 31.2 ± 5.9 | 33.5 ± 5.0 | 0.016 | 30.6 ± 3.7 | 32.8 ± 5.8 | 0.016 |
| Z-score basal diameter* | 1.6 ± 0.9 | 1.7 ± 0.8 | 0.17 | 1.5 ± 0.8 | 1.6 ± | 0.240 |
| TAPSE (mm)* | 24.1 ± 5.0 | 23.2 ± 3.4 | 0.59 | 22.5 ± 3.9 | 23.9 ± 4.3 | 0.170 |
| Shortening fraction (%)* | 38.7 ± 7.6 | 39.9 ± 8.15 | 0.37 | 38.6 ± 7.9 | 43.2 ± 1.01 | 0.016 |
| S’ wave (cm/s)* | 12.6 ± 2.3 | 13.3 ± 2.5 | 0.09 | 13 ± 2.1 | 13 ± 2.5 | 0.990 |
| E/A ratio* | 1.4 ± 0.2 | 1.7 ± 0.6 | 0.48 | 1.8 ± 0.34 | 1.7 ± 0.37 | 0.330 |
| E’ wave (cm/s)* | 39 ± 19 | 49 ± 29 | 0.04 | 16.3 ± 20 | 17 ± 26 | 0.580 |
| E’ wave z-score* | − 0.53 ± 1.10 | − 0.19 ± 1.17 | 0.082 | − 0.15 ± 0.71 | − 0.29 ± 1.2 | 0.370 |
| E/E’ ratio* | 3.9 ± 1.5 | 3.3 ± 1.02 | 0.017 | 3.7 ± 1.3 | 3 ± 0.9 | 0.029 |
| E/E’ ratio z-score* | 0.2 ± 1.3 | − 0.3 ± 0.9 | 0.006 | 0.33 ± 0.95 | − 0.03 ± 1.2 | 0.030 |
| Myocardial performance index (MPI)* | 0.39 ± 0.13 | 0.32 ± 0.08 | < 0.001 | 0.36 ± 0.11 | 0.31 ± 0.09 | 0.060 |
| MPI z-score* | 0.61 ± 1.1 | − 0.6 ± 0.72 | 0.01 | 0.59 ± 0.85 | − 0.38 ± 0.94 | 0.090 |
*Mean ± standard deviation.
TAPSE, Tricuspid annular plane systolic excursion; MPI, myocardial performance index.
Values of left ventricle’s morphology and function obtained by echocardiography in very preterm and moderately-late preterm adolescents.
| < 32 weeks N = 74 | ≥ 32 weeks N = 74 | IUGR N = 20 | Non-IUGR N = 128 | |||
|---|---|---|---|---|---|---|
| Left ventricle diastolic diameter (mm)* | 44.0 ± 4.2 | 45.4 ± 4.3 | 44.6 ± 4.9 | 44.7 ± 4.2 | 0.920 | |
| Left ventricle diastolic diameter z-score* | − 0.29 ± 1.26 | − 0.21 ± 1 | − 0.38 ± 1.5 | − 0.23 ± 1.08 | 0.590 | |
| Interventricular septum (diastole) (mm)* | 6.9 ± 1.2 | 7.3 ± 1.2 | 6.9 ± 1.2 | 7.2 ± 1.2 | 0.410 | |
| Interventricular septum z-score* | − 0.13 ± 0.76 | 0.10 ± 0.78 | − 0.23 ± 0.65 | − 0.1 ± 0.78 | 0.470 | |
| Left posterior wall (diastole) (mm)* | 7.2 ± 1,7 | 7.36 ± 1.2 | 7.12 ± 1.2 | 7.4 ± 1.2 | 0.290 | |
| Left posterior wall z z-score* | 0.2 ± 0.9 | 0.3 ± 0.5 | 0.41 ± 0.27 | 0.83 ± 0.94 | 0.480 | |
| Shortening fraction (%) | 38.8 ± 4.3 | 39.4 ± 4.8 | 38.2 ± 4.2 | 39.1 ± 4.6 | 0.430 | |
| Ejection fraction (%) | 68.8 ± 5.6 | 69.9 ± 5.5 | 68.5 ± 5.3 | 69.5 ± 5.5 | 0.650 | |
| S’ wave velocity (cm/s)* | 11.4 ± 3.1 | 12.4 ± 1.4 | 10.8 ± 3.2 | 13.5 ± 1.06 | 0.120 | |
| S’ wave velocity z-score* | − 0.28 ± 1.3 | − 0.1 ± 1.04 | − 0.44 ± 1.2 | − 0.02 ± 1.1 | 0.650 | |
| E’ wave velocity (cm/s)* | 18.5 ± 3.5 | 21.5 ± 2.7 | 17.5 ± 2.04 | 19.7 ± 0.3 | 0.690 | |
| E’ wave velocity z-score* | − 0.47 ± 1.04 | − 0.06 ± 0.8 | − 0.14 ± 1.04 | − 0.27 ± 0.95 | 0.570 | |
| E/E’ ratio* | 5.2 ± 1.1 | 4.2 ± 1.1 | 4.5 ± 1.4 | 4.3 ± 1.0 | 0.710 | |
| E/E’ ratio z-score* | 0.66 ± 0.79 | − 0.35 ± 0.83 | − 0.31 ± 0.99 | − 0.23 ± 0.82 | 0.760 | |
| Septal MPI* | 0.37 ± 0.09 | 0.29 ± 0.05 | 0.32 ± 0.06 | 0.32 ± 0.08 | 0.560 | |
| Septal MPI z-score* | 0.32 ± 0.85 | 0.10 ± 1.02 | − 0.7 ± 0.84 | − 0.74 ± 0.78 | 0.830 | |
| Lateral MPI* | 0.32 ± 0.09 | 0.28 ± 0.05 | 0.30 ± 0.08 | 0.30 ± 0.06 | 1 | |
| Lateral MPI z-score* | 0.19 ± 0.86 | 0.11 ± 0.76 | − 0.7 ± 0.71 | − 0.97 ± 0.7 | 0.140 |
Mean ± standard deviation.
MPI, myocardial performance index.